Akso Health (AHG) Cash & Equivalents (2017 - 2026)

Akso Health (AHG) has 10 years of Cash & Equivalents data on file, last reported at $200000.0 in Q1 2026.

• Quarterly Cash & Equivalents fell 99.89% year-over-year to $200000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $200000.0 (down 99.89% YoY) and the FY2026 annual result came in at $200000.0, down 99.89% from the prior year.
• Cash & Equivalents slipped to $200000.0 in Q1 2026, from $11.1 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $176.2 million in Q1 2025 to a low of $4472.0 in Q1 2023.
• A 5-year average of $42.6 million and a median of $10.0 million in 2022 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2022 — Cash & Equivalents surged 64635172.77% — and 2026, when it plunged 99.89%.
• Tracing AHG's Cash & Equivalents over 5 years: stood at $10.0 million in 2022, then declined by 7.8% to $9.2 million in 2023, then jumped by 891.87% to $91.4 million in 2024, then tumbled by 87.82% to $11.1 million in 2025, then plunged by 98.2% to $200000.0 in 2026.
• The last three Cash & Equivalents figures came in at $200000.0 (Q1 2026), $11.1 million (Q3 2025), and $176.2 million (Q1 2025), per Business Quant data.